Company Overview
| Stock Name | 廣東康華醫療股份有限公司 - Ｈ股 |
|---|---|
| Stock Code | 03689 |
| Company Full Name | 廣東康華醫療股份有限公司 - Ｈ股 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國經營綜合醫院服務。 |
| Listing Date | 2016-11-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省東莞市東莞大道1000號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.kanghuagp.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 11.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 5.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 35,714,080 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 10.6 |
|---|---|
| First Day Open | HK$ 11.5 |
| First Day Change | -8.62% |
| First Day Volume | 11178400.0 |
| First Day Turnover | 120905000.0 |
Use of Proceeds
| Use of Proceeds | 1、約90.4百萬港元 （或所得款項凈額9%）將用于擴大及增加康華醫院及仁康醫院現有的醫療保健服務； 2、約361.6百萬港元（或所得款項凈額36%）將用于擴大我們在多學科專業治療及診斷方面的營運能力以及多學科專業治療及診斷的能力以及升級康華醫院及仁康醫院的醫療設施； 3、約100.5百萬港元（或所得款項凈額10%）將用于與中國的第三方醫院擴展我們醫院的咨詢及管理業務； 4、約351.6百萬港元（或所得款項凈額35%）將用于擴展我們在中國的醫療保健業務，包括透過選擇性并購其他醫院； 5、約100.5百萬港元（或所得款項凈額10%）將撥作營運資金及作其他一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (1)
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (4)
中国国际金融香港证券有限公司 CE AEN894
招银国际融资有限公司 CE AVM940
农银国际融资有限公司 CE AWL249
交银国际证券有限公司 CE APJ121
Joint Lead Managers (5)
中国国际金融香港证券有限公司 CE AEN894
招银国际融资有限公司 CE AVM940
农银国际融资有限公司 CE AWL249
交银国际证券有限公司 CE APJ121
兆邦基国际融资有限公司
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 升鹏有限公司 | 206,897,600 HKD | — | 5.34% | — | 6 months | 2017-05-08 |
Directors & Management
| Chairman | 王君揚 |
|---|---|
| Company Secretary | 黃偉恒,周慶齡 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 王君揚及家族成員(66.54%);陳旺枝(8.22%) |
|---|
